bs-43196P
[Protein]
Recombinant SARS-Cov-2 Spike protein RBD(EG.5), (HEK293)
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET
Entrez Gene: 43740568
Swiss Prot: P0DTC2
Source: Recombinant SARS-Cov-2 Spike protein RBD(EG.5) is expressed in HEK293 cell with C-His. It contains the amino acid sequence of 319-537/1273
Storage Buffer: 0.01M TBS(pH7.4)
Storage: The product should be stored at -70°C or -20°C.
Background:
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
Size: 100ug,500ug,20ug
Applications: Others()
Mol. Wt.: 26.5
Species: Others
For research use only. Not intended for diagnostic or therapeutic use.